MEDTRONIC ANNOUNCES REIMBURSEMENT APPROVAL IN FRANCE FOR THE ENDEAVOR DRUG-ELUTING CORONARY STENT SYSTEM

Medtronic, Inc. today announced that it has received reimbursement approval in France for the Endeavor drug-eluting coronary stent (DES) system. The announcement was made following publication in the official French government journal, "Journal Officiel de la Republique Francaise," on June 8, 2006. Finanzen.net (http://finanzen.net/news/news_detail.asp?NewsNr=405938)